Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers

Clinical trial NCT02867852 · COMPLETED

Trial details

NCT number: NCT02867852
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Salivary Glands Tumors

Start date: 2015-03-01
Primary completion: 2019-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.